Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Leading global contract research organizations based on revenue 2017

Top global contract research organizations (CROs) based on 2017 revenue (in million U.S. dollars)

by Matej Mikulic, last edited May 27, 2019
Leading global contract research organizations based on revenue 2017 In 2017, the top contract research organizations worldwide included Laboratory Corporation of America Holdings, IQVIA, and Syneos Health, to name a few. The top company, Laboratory Corporation of America Holdings had 10.4 billion U.S. dollars in revenue during that year. Comparatively, the second company IQVIA generated 9.7 billion U.S. dollars in revenue.
Contract research organizations

Contract research organizations (CROs) are companies that are contracted by larger pharmaceutical companies to manage select aspects of clinical trials. Today, CROs are essential for pharmaceutical research and development. Pharmaceutical companies are spending more money than ever on research and development and there is no indication that spending will decrease in the future. Evidence suggests that CROs will become even more valuable. The clinical CRO market is expected to almost double by 2020. Likewise, it is expected that by 2021 revenue generated by CROs will nearly double the revenue generated by CROs in 2016.

Pharmaceutical research and development

Globally, Roche and Johnson & Johnson will be the top pharmaceutical companies based on their projected research and development spending. There are regional differences in research and development among pharmaceutical companies. Of all pharmaceutical companies globally those based in the U.S. developed the most new chemical or biological entities between 2013 and 2017.
Show more

Top global contract research organizations (CROs) based on 2017 revenue (in million U.S. dollars)

Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Download Settings Share
Download started
Please be patient - this may take a moment
by Matej Mikulic, last edited May 27, 2019
In 2017, the top contract research organizations worldwide included Laboratory Corporation of America Holdings, IQVIA, and Syneos Health, to name a few. The top company, Laboratory Corporation of America Holdings had 10.4 billion U.S. dollars in revenue during that year. Comparatively, the second company IQVIA generated 9.7 billion U.S. dollars in revenue.
Contract research organizations

Contract research organizations (CROs) are companies that are contracted by larger pharmaceutical companies to manage select aspects of clinical trials. Today, CROs are essential for pharmaceutical research and development. Pharmaceutical companies are spending more money than ever on research and development and there is no indication that spending will decrease in the future. Evidence suggests that CROs will become even more valuable. The clinical CRO market is expected to almost double by 2020. Likewise, it is expected that by 2021 revenue generated by CROs will nearly double the revenue generated by CROs in 2016.

Pharmaceutical research and development

Globally, Roche and Johnson & Johnson will be the top pharmaceutical companies based on their projected research and development spending. There are regional differences in research and development among pharmaceutical companies. Of all pharmaceutical companies globally those based in the U.S. developed the most new chemical or biological entities between 2013 and 2017.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Pharmaceutical research and development
Pharmaceutical research and development

All Information
in one Presentation

Pharmaceutical research and development

Everything On "Pharmaceutical research and development" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Clinical trials"
  • R&D overview
  • Top R&D companies
The most important statistics
  • Clinical studies
  • Participation
  • Costs and market
  • Success rates
  • Approvals, launches, setbacks
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.